Get started
Author

Nataliia Verovkina

Observed names: N. O. Verovkina, N. Verovkina, N.O. Verevkina, N.O. Verovkina, Верьовкіна, Н.О., Н.О. Верьовкіна
Observed institutions: Brown University, Ministry of Health, National Cancer Institute, National Cancer Institute, Lifespan, Institute of Molecular Biology and Genetics
ORCID: 0000-0002-6687-4494
Observed ORCID: 0000-0002-6687-4494
OpenAlex ID: A5068868052
Targeting apoptotic pathways for cancer therapy
2024 · Xiaobing Tian, Praveen R. Srinivasan, et al. · Journal of Clinical Investigation · 166
PDF
Signaling pathway dysregulation in breast cancer
2025 · Dinara Ryspayeva, Attila A. Seyhan, et al. · Oncotarget · 32
Acquired resistance to molecularly targeted therapies for cancer
2025 · Nolan M. Stubbs, Tyler S. Roady, et al. · Cancer Drug Resistance · 31
PDF
Prognostic role of androgen receptor expression in patients with metastatic triple negative breast cancer
2020 · S.A. Lyalkin, N.O. Verevkina, et al. · Experimental Oncology · 15
PDF
Corrigendum to Targeting apoptotic pathways for cancer therapy
2025 · Xiaobing Tian, Praveen R. Srinivasan, et al. · Journal of Clinical Investigation · 3
PDF
Her2low breast cancer. New opportunities and challenges
2022 · N.O. Verovkina, S.A. Lyalkin, et al. · Український радіологічний та онкологічний журнал · 2
PDF
Tristetraprolin expression levels and methylation status in breast cancer
2022 · Serhii Kropyvko, Anastasiia Hubiernatorova, et al. · Gene Reports · 2
Особливості поліморфізму генів TLR-2, TLR-4, TLR-9 та їхня роль у перебігу та прогнозі тричі негативного раку грудної залози
2019 · Національний інститут раку, Київ, С.А. Лялькін, et al. · Clinical Oncology · 2
PDF
CD8+, CD4+ and FOXP3+ cell profiles and their change after neoadjuvant chemotherapy in patients with triple negative breast cancer
2018 · N.O. Verovkina, S. Lyalkin, et al. · Annals of Oncology · 2
70P Genetic polymorphisms of ESR1 are associated with hormone resistance to aromatase inhibitors therapy in patients with metastatic luminal breast cancer (MLBC)
2020 · T. Tarasenko, L.A. Syvak, et al. · Annals of Oncology · 1
Characterization of S6K1 isoform mRNA expression in molecular subtypes of human breast tumors
2026 · I. V. Kroupskaya, A. V. Mazov, et al. · Biopolymers and Cell
PDF
Differential expression of TKS4 isoforms and their role in cellular processes in breast cancer
2026 · Serhii Kropyvko, Nazar Shevchuk, et al. · Journal of Cell Communication and Signaling
ZFP36 expression profiles in breast tumors of different stages and hormonal receptor status
2024 · A. O. Hubiernatorova, L. A. Syvak, et al. · Biopolymers and Cell
PDF
Abstract 4854: Breast cancer incidence trends in Ukraine 2010-2019: Rising incidence at young ages
2024 · Nataliia Verovkina, Olena Sumkina, et al. · Cancer Research
Prognostic Role of Residual Tumor Features in Her2-negative Breast Cancer
2023 · L.A. Sivak, S.A. Lyalkin, et al. · Experimental Oncology
PDF
Characteristics of patients with metastatic luminal breast cancer (MLBC) and ESR1 polymorphism
2022 · T. Tarasenko, L. Syvak, et al. · European Journal of Cancer
Ефективність другої лінії паліативної хіміотерапії у хворих на метастатичний тричі негативний рак молочної залози: результати рандомізованого дослідження
2020 · Національний інститут раку, Київ, С.А. Лялькін, et al. · Український медичний часопис
The Role of the Allelic Polymorphism of the Ccr5 Gene in Locally Advanced Breast Cancer of Various Molecular Subtypes and Its Effect on the Effectiveness of Neoadjuvant Chemotherapy
2019 · Nataliia Verovkina, Liubov Sivak, et al. · The Breast
Prediction of Individual Sensitivity for Chemotherapy
2018 · L. A. Syvak, S. A. Lyalkin, et al. · Likarska sprava
The correlation between toll-like receptor genes polymorphisms, tumor microenvironment characteristics and the effectiveness of preoperative chemotherapy for locally advanced breast cancer
2017 · N. Verovkina, L.A. Sivak, et al. · Annals of Oncology
PDF
Роль иммунного микроокружения в развитии рака молочной железы
2017 · L. A. Sivak, A. N. Grabovyj, et al. · Likarska sprava
PDF
Нейротоксичність сучасних протипухлинних препаратів
2016 · L. A. Sivak, S. A. Lyalkin, et al. · Likarska sprava
PDF
Prognostic and predictive value of CD8 + , CD4 + infiltration and KI-67 level in the post-chemotherapy residual disease in triple negative breast cancer
2015 · N.O. Verovkina, L.A. Syvak, et al. · Annals of Oncology
PDF
Works count: 24
Citation count: 256
H-index: 4
I10-index: 4
Year
Topic
Type